期刊文献+

鄂中地区8136例妇女HPV感染导流杂交法亚型检测的临床意义 被引量:5

Genotypic Subtypes Detection of Human Papillomavirus by Using Flow-through Hybridization in 8136 Local Women Living in the Cen- ter of Hubei Province
原文传递
导出
摘要 目的分析鄂中地区人群HPV感染基因型别。方法采集8136例鄂中地区2009年8月至2010年7月武汉市商业职工医院门诊与住院患者宫颈口及颈管脱落上皮细胞,应用导流杂交法进行HPV分型检测。结果HPV阳性感染1437例(17.66%),其中高危型感染检出1189例(占82.67%),低危型感染检出141例(占9.74%),中国人群常见亚型感染检出305例(占21.16%),多重感染检出369例(26.68%)。单一感染者中高危型833人(57.97%),低危型感染者72人(5.01%),中国人群常见亚型感染者163人(11.34%)。根据年龄分层,〈25岁组HPV感染率相对较高,为21.17%(P〈0.05);HPV高危型感染组中〈25岁比例较高,达17.80%。在1437例HPV阳性感染者中,单一感染者共1068例(74.32%),二重感染占18.72%。最常见的交叉感染是高危型+中国人群常见亚型合并感染(8.28%)。结论导流杂交法HPV基因型分型检测可为宫颈疾病流行病学及早筛早治提供重要线索,对于发现HPV感染的高危人群、积极控制HPV感染、具有重要意义。 Objective To evaluate the clinically applied value of flow-through hybridization for identifying human papillomavirus (HPV) genotypes of the local women living in the center of Hubei province. Methods From Aug. 2009 to July 2010, 8136 cases were recruited and the cervical cell samples were collected and detected for HPV genotypes by using flow-through hybridization. Results 1 437 of 8 136 cases were detected with HPV-positive infection ( 17.66 % ), including 1 189 cases of high-risk HPV (HR-HPV) infection (82.67 % ), 141 eases of low-risk HPV (LR-HPV) infection (9.74 % ), 305 cases of Chinese population HPV (CP-HPV) infection (21.16 % ), as well as 369 cases of multiple HPV infection (26.68 % ) . As for single infection, 833 patients were identified with HR-HPV subtypes (57.97 % ), 72 cases (5.01% ) with LR-HPV subtypes and 163 cases (11.34 % ) with CP-HPV subtypes. Compared with that in the other subgroups, the HPV positive rate in the women less than 25 years old was significantly increased (21.17 %, P〈0. 05) . So was the positive rate of HR-HPV (17.80 %) . In a total of 1437 cases of HPV-positive infection, 74. 32 % were involved in single infection, and 18.72 % in superinfection. The most common cross-infection was HR-HPV plus CP-HPV subtype infection (8.28 % ) . Conclusion The technology of flow-through hybridization for HPV genotypes provides important clues for the epidemiological research, early screening and treatment of cervical diseases, which plays an important role in identifying high-risk groups and effectively controlling HPV infection.
出处 《医学分子生物学杂志》 CAS CSCD 2010年第5期425-429,共5页 Journal of Medical Molecular Biology
基金 资助项目:国家重点基础研究发展规划项目(973计划)(No.2009CB521800)
关键词 人乳头瘤状病毒 感染 基因型 导流杂交 宫颈疾病 humanpapilloma virus infection genetype flow-through hybridization cervical disease
  • 相关文献

参考文献7

  • 1PELTECU G,BARI M,LANCU G,et al.Human papilloma virus and cervical preinvasive disease[J].J Med Life,2009,2(4):373-377.
  • 2ZUR H H.Cervical carcinoma and human papillomavirus:OU the road to preventing a major human cancer[J].J Natl Cancer lnst,2001,93(4):252-253.
  • 3赵健,杨英捷,廖秦平.导流杂交基因芯片技术在人乳头状瘤病毒感染分型检测中的临床应用[J].中华检验医学杂志,2006,29(12):1148-1151. 被引量:81
  • 4MUNOZ N,BOSCH F X,CASTELLSAGUE X,et al.Against which human papillomavirus types shall we vaccinate and screen? The international perspective[J].Int J Cancer,2004,111(2):278-285.
  • 5HLAING T,YIP Y C,NGAI K L,et al.Distribution of human papillomavirus genotypes among cervical intraepithelial neoplasia and invasive cancers in Macao[J].J Med Virol,2010,82(9):1600-1605.
  • 6BEKKERS R L,MASSUGER L F,BULTEN J,et al.Epidemidogi-cal and clinical aspects of human papillomavirus detection in the prevention of cervical cancer[J].Rev Med virol,2004,14(2):95-105.
  • 7LAZCANO-PONCE E,HERRERO R,MUNOZ N,et al.Epidemio-logy of HPV infection among maxican women with normal cervical cytology[J].Int J Cancer,2001,91:412-420.

二级参考文献10

  • 1乌兰娜,吴瑞芳,周艳秋,刘志红,张礼婕,黄秀浓,杜辉.人乳头瘤病毒基因亚型与宫颈病变的关系[J].中国妇产科临床杂志,2005,6(5):346-350. 被引量:102
  • 2金冬雁 黎孟枫译(J.萨姆布鲁克 E.F.弗里奇 T.曼尼阿蒂斯著)[M].分子克隆实验指南(第2版)[M].北京:科学出版社,1999..
  • 3Munoz N,Bosch FX,Sanjose S,et al.Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer.N Engl J Med,2003,348:518-527.
  • 4Maumoto N,Fujii T,Ishikawa M,et al.Dominant human papillomavirus 16 infection in cervical neoplasia in young Japanese women; study of 881 outpatients.Gyunecol Oncol,2004,94:509-514.
  • 5Nieminen P,Vuorma S,Viikki M,et al.Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.BJOG,2004,111:842-848.
  • 6Lizano M,De la Cruz-Hernandez E,Carrillo-Garcia A,et al.Distribution of HPV16 and 18 intratypic variants in normal cytology,intraepithelial lesions,and cervical cancer in a Mexican population.Gynecol Oncol,2006,102:230-235.
  • 7Burk RD,Terai M,Gravitt PE,et al.Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix.Cancer Res,2003,63:7215-7220.
  • 8Ault KA.Epidemiology and natural history of human papillomavirus infections in the female genital tract.Infect Dis Obstet Gynecol.2006,14:40470.
  • 9Clifford GM,Smith JS,Plummer M,et al.Human papillomavirus types in invasive cervical cancer worldwide:a meta-analysis.Br J Cancer,2003,88:63-73.
  • 10Berman NR.Cervical cancer screening today.The role of HPV DNA testing.Adv Nurse Pract.2006,14:24-29.

共引文献80

同被引文献59

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部